Skip to main content
Figure 4 | Molecular Cancer

Figure 4

From: Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

Figure 4

GFP-LIMK1 fusions increase phosphorylation status of FAK signaling components. (A) Western blot analysis of whole cell lysates from MDA-MB-231 stable transductants probed with antibodies against pFAK, total FAK, pPaxillin, total Paxillin, pSrc, total Src, pAKT, total AKT, pErk1/2 and total Erk 1/2. (B) Western blot analysis for tubulin or GAPDH for each extract used in panel A, as loading controls.

Back to article page